BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38035181)

  • 1. Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients.
    Hamdaoui H; Nouadi B; Benlarroubia O; Chbel F; Saadoune C; Bennis F; Lamzouri A; Chegdani F
    Leuk Res Rep; 2023; 20():100392. PubMed ID: 38035181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients.
    Hamdaoui H; Benlarroubia O; Ait Boujmia OK; Mossafa H; Ouldim K; Belkhayat A; Smyej I; Benrahma H; Dehbi H; Chegdani F
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1363. PubMed ID: 32573970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
    Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
    Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].
    Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]   [Full Text] [Related]  

  • 6. Conventional and molecular cytogenetic analyses in Turkish patients with multiple myeloma.
    Durak BA; Akay OM; Sungar G; Bademci G; Aslan V; Caferler J; Ozdemir M; Cilingir O; Artan S; Gülbaş Z
    Turk J Haematol; 2012 Jun; 29(2):135-42. PubMed ID: 24744644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.
    Debes Marun CS; Belch AR; Pilarski LM
    Am J Hematol; 2012 Jun; 87(6):579-87. PubMed ID: 22495885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
    Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
    Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].
    Wang YF; Wang H; Xi LY; Liu Y; Dong F; Wang JJ; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1352-6. PubMed ID: 26524036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
    Lai YY; Huang XJ; Cai Z; Cao XS; Chen FP; Chen XQ; Chen BA; Fang MY; Feng JF; Fu WL; Guo HY; Hou M; Hou J; Hu Y; Hu XT; Hu XM; Huang LQ; Jin J; Li JY; Li J; Li W; Liang YM; Liu T; Liu QF; Liu YH; Mao P; Ouyang J; Qiu LG; Qiu L; Shao CK; Shi B; Song YP; Sun ZM; Wang QS; Wang C; Wang JM; Wang YS; Wang Z; Wu JB; Wu YX; Xia RX; Xue YQ; Yang BZ; Yang G; Yang ZL; Yu L; Yuan Z; Zhang S; Zhang Y; Zhao HG; Zhao L; Zhou DB; Zou SH; Zhu YF
    Chin Med J (Engl); 2012 Aug; 125(15):2663-70. PubMed ID: 22931972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].
    Li QZ; Tan K; Liu YX; Huang H; Zhang Y; Chen HM; Chen ZZ; Zhu ZW; Yang BH; Hu GY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1496-1500. PubMed ID: 36208255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells.
    Kishimoto RK; de Freitas SL; Ratis CA; Borri D; Sitnik R; Velloso ED
    Rev Bras Hematol Hemoter; 2016; 38(2):113-20. PubMed ID: 27208569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
    Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
    He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
    Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
    Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
    Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization.
    Hu Y; Chen W; Chen S; Huang Z
    Onco Targets Ther; 2016; 9():1145-9. PubMed ID: 27042105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.
    Gao X; Li C; Zhang R; Yang R; Qu X; Qiu H; Xu J; Lu H; Li J; Chen L
    Med Oncol; 2012 Sep; 29(3):2200-6. PubMed ID: 21611837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.